Shubham Pant, MD

Articles

Dr. Pant on the Role of Genetic Testing in Pancreatic Cancer

October 29th 2020

Shubham Pant, MD, discusses the role of genetic testing in pancreatic cancer.

Dr. Pant on Targeting KRAS Mutations in Metastatic Solid Tumors

August 27th 2020

Shubham Pant, MD, discusses targeting KRAS mutations in advanced or metastatic solid tumors.

Dr. Pant on Choosing Therapy for Frontline and Beyond in Pancreatic Cancer

April 3rd 2020

Shubham Pant, MD, discusses choosing therapy for the frontline and beyond in pancreatic cancer.

Dr. Pant on Exciting Data With PARP Inhibitors in Pancreatic Cancer

March 13th 2020

Shubham Pant, MD, discusses exciting data with PARP inhibitors in pancreatic cancer.

Dr. Pant on Immunotherapy Combos and Upcoming Developments in Pancreatic Cancer

March 10th 2020

Shubham Pant, MD, discusses combination immunotherapies and upcoming developments in pancreatic cancer.

Dr. Pant on the Future of mCRC Treatment

March 28th 2018

Shubham Pant, MD, associate medical director of the Clinical & Translational Research Center, associate professor, Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, discusses ongoing efforts in metastatic colorectal cancer (mCRC) and his hope for the future treatment landscape.

Dr. Pant on the Third-Line Setting for Metastatic CRC

December 6th 2017

Shubham Pant, MD, associate professor, The University of Texas MD Anderson Cancer Center, discusses the third-line setting for patients with metastatic colorectal cancer (CRC).

Dr. Pant Discusses the Current Treatment Landscape of CRC

November 22nd 2017

Shubham Pant, MD, associate professor, The University of Texas MD Anderson Cancer Center, discusses the current treatment landscape of colorectal cancer.